Is berberine really nature's Ozempic? The trial evidence says no

The supplement went viral on TikTok as a natural stand-in for semaglutide. The randomized trials tell a smaller, more honest story: real but modest effects on blood sugar and cholesterol, and weight loss measured in a pound or two, not the double-digit percentages GLP-1 drugs deliver.

Published by the editorial staff of Health Trend Wire

Berries on a barberry shrub, one of the plants berberine is extracted from. The yellow alkaloid is real; its effects are not Ozempic-sized.
Photo: Miroslaw LT / Pexels

In the summer of 2023, a supplement most people had never heard of started trending on TikTok under a very large promise. Berberine, a bitter yellow compound pulled from plants like barberry and goldenseal, was being sold as "nature's Ozempic": a cheap, over-the-counter way to get the blood-sugar and weight benefits of the injectable drugs everyone was suddenly talking about. The compound is real, and so are some of its effects. The comparison to Ozempic is not.

Where the label came from

Berberine is not new. It has been used in traditional Chinese and Ayurvedic medicine for centuries and studied for its effects on blood sugar and cholesterol for decades. What was new in 2023 was the framing. As semaglutide, sold as Ozempic and Wegovy, became a cultural phenomenon and a supply-constrained one, wellness influencers went looking for a natural stand-in, and berberine fit the story they wanted to tell: a plant extract that lowers glucose, available at any supplement shop for a fraction of the price. The nickname stuck. It was a marketing line, not a research conclusion, and the doctors who actually study obesity were quick to say so when reporters started calling.

What the trials actually show

Strip away the hashtag and there is a genuine body of evidence underneath. A 2022 dose-response meta-analysis in Frontiers in Nutrition pooled 49 randomized trials and found berberine did move the numbers. Fasting blood glucose fell by about 7.7 mg/dL, HbA1c by 0.45 percentage points, LDL cholesterol by roughly 9.6 mg/dL and triglycerides by about 24 mg/dL. Those are real, useful shifts, broadly in the range you might get from a determined lifestyle change or a low-dose medication. If berberine were marketed as a modest metabolic supplement, the science would mostly back the pitch.

The weight numbers are where the Ozempic comparison falls apart.

The honest comparison is not close: berberine's pooled weight effect is under two pounds, against roughly 15 percent of body weight for semaglutide.
The honest comparison is not close: berberine's pooled weight effect is under two pounds, against roughly 15 percent of body weight for semaglutide. Photo: Cup of Couple / Pexels

That is the honest headline figure. Across the same 49 trials, berberine's average effect on body weight was about 0.84 kilograms, less than two pounds, usually measured over three to six months. In the STEP 1 trial, by contrast, adults on semaglutide lost an average of 14.9 percent of their body weight over 68 weeks, against 2.4 percent on placebo. Dr. Justin Ryder, an obesity researcher at Northwestern, put the gap in blunt terms when he spoke to CNN: pooled across studies, berberine reduced BMI by about 0.25 units versus placebo, while semaglutide and its higher-dose sibling Wegovy reduced it by 4.61 units, close to eighteen times more.

The two also work nothing alike. Berberine activates AMPK, a cellular energy enzyme that nudges the body toward using glucose. GLP-1 drugs mimic a gut hormone that slows digestion and dials down appetite directly. Similar destination on a lab report, completely different engine, and only one of them has been put through large trials designed to measure weight loss.

“As for it being nature's Ozempic, there's no evidence to suggest that is true.”

Dr. Caroline Apovian, obesity physician, Harvard Medical School and Brigham and Women's Hospital, to CNN, July 2023

The one comparison that holds up

There is a fairer analogy hiding in the research, and it is not Ozempic. In several small head-to-head trials, berberine's effect on blood sugar looked similar to metformin, the cheap first-line diabetes drug. A 2012 systematic review in Evidence-Based Complementary and Alternative Medicine pooled 14 trials and 1,068 patients and found no significant difference between berberine and oral drugs like metformin or glipizide on fasting glucose or HbA1c. The catch sits in the same paper. Its authors wrote that most of the included trials were of poor quality, with unclear randomization and weak blinding, and that only one qualified as a properly controlled study. Comparable results from low-quality trials are a promising signal to run better trials, not proof that a capsule can stand in for a prescription.

The problems the label skips

Even judged on its own terms, berberine carries practical problems the viral version leaves out. It is poorly absorbed. A 2023 pharmacokinetic study in Pharmaceutics reports that 5 percent or less of an oral dose reaches the bloodstream in humans, and under 1 percent in animal work, because the compound is broken down in the gut and liver and pumped straight back out by transport proteins. That same poor absorption is why it tangles with other medicines: berberine is processed through the CYP3A4 and P-glycoprotein pathways that handle many common drugs, so it can push their levels up or down.

Then there is what is actually in the bottle. Cleveland Clinic lists nausea, abdominal discomfort, constipation and diarrhea as berberine's common side effects, notes that it can interact with medications, and flags the detail that matters most for anything sold on social media: supplements like berberine are not regulated by the U.S. Food and Drug Administration, so the dose and purity you get are not guaranteed to match the label.

“Does berberine have an effect? The data would suggest yes. Is the effect meaningful? Probably not.”

Dr. Justin Ryder, obesity researcher, Northwestern University Feinberg School of Medicine, to CNN, July 2023

Who should be careful

The people with the most to lose from the hype are often the ones the videos are aimed at. Anyone already taking medication for diabetes, blood pressure or cholesterol can drive their numbers too low or set off an interaction by stacking berberine on top, which is why the clinicians quoted here stress checking with a doctor before adding it. Cleveland Clinic advises against berberine during pregnancy and breastfeeding and says it is not for children. And anyone reaching for it as a replacement for a prescribed GLP-1 drug, or as a cheaper entry point alongside the parallel trend of microdosing GLP-1 medications, is swapping a heavily tested treatment for a much weaker one.

Our take

Berberine is a real compound with real, modest effects on blood sugar and blood lipids, and a small effect on weight. That makes it a legitimate supplement and a worthwhile research target. It does not make it Ozempic. The best-measured weight effect is under two pounds, set against a drug that reliably removes ten to fifteen percent of body weight, and the studies that make berberine look like a match for metformin are mostly too weak to bank on. "Nature's Ozempic" was a good line. The evidence underneath it is a much quieter story, and it is worth telling accurately.

Sources

  1. 3

    Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis, Evidence-Based Complementary and Alternative Medicine (Dong et al.)

  2. 4

    Berberine for Weight Loss: Does It Work?, Cleveland Clinic (reviewed by Layth Tumah, MD)

  3. 5

    STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity, American College of Cardiology (STEP 1 trial summary)